Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
CD BioGlyco Launches Next-Gen Antibody Glycan Remodeling for Precision Therapeutics
Continuing to solidify their position as a global leader in the field of Glycoengineering, CD BioGlyco is proud to launch its next generation Antibody Glycan Remodeling Service, which provides researchers and pharmaceutical developers with a powerful platform for producing targeted glycoforms of their antibodies’ Fc region. By using cutting-edge chemoenzymatic technology powered by...
0 Comments ·0 Shares ·71 Views ·0 Reviews
Please log in to like, share and comment!